Late Adv. Dadasaheb Chavan Memorial Institute of Pharmacy, Malwadi, Masur, 415106, MS, India.
Herbal medicines play a vital role in global healthcare due to their therapeutic efficacy and favorable safety profile. However, their clinical application is often limited by poor aqueous solubility, instability, rapid metabolism, and low bioavailability of active phytoconstituents. In recent years, nanotechnology has emerged as an innovative platform to overcome these limitations by enhancing the delivery and effectiveness of plant-derived bioactive compounds. Various nanocarrier systems, including polymeric nanoparticles, solid lipid nanoparticles, liposomes, nanoemulsions, dendrimers, and phytosomes, have demonstrated improved drug solubilization, enhanced pharmacokinetics, and targeted delivery to specific tissues.Recent advances highlight the development of green-synthesized plant-based nanoparticles, stimuli-responsive (smart) nanocarriers, and artificial intelligence-assisted formulation design, which improve therapeutic precision and reduce systemic toxicity. The integration of nanotechnology with herbal medicine has led to the emergence of nano-phytomedicine, where encapsulation of phytochemicals enhances stability, bioavailability, and biological activity. Additionally, ligand-functionalized nanoparticles, mucoadhesive systems, and intranasal nanoformulations have enabled targeted drug delivery, particularly for neurological disorders and cancer therapy. These systems also exploit the enhanced permeability and retention (EPR) effect, allowing preferential accumulation in diseased tissues and improving therapeutic outcomes.Furthermore, advancements in nanomaterial engineering, including surface modification and hybrid nanocarriers, have expanded applications in chronic diseases, antimicrobial resistance, and metabolic disorders. Despite these promising developments, challenges such as nanotoxicity, lack of standardization, regulatory uncertainties, and scale-up difficulties remain significant barriers to clinical translation. Therefore, future research should focus on improving safety, developing cost-effective manufacturing techniques, and establishing robust regulatory frameworks. Overall, nano-based herbal drug delivery systems represent a promising approach for enhancing the clinical potential of herbal therapeutics and advancing modern healthcare.
Herbal medicines have been utilized for centuries as an essential component of traditional healthcare systems and continue to contribute significantly to modern therapeutics. A large proportion of the global population still relies on plant-based remedies due to their wide availability, cost-effectiveness, and relatively low incidence of adverse effects. Bioactive constituents such as alkaloids, flavonoids, terpenoids, and polyphenols possess diverse pharmacological activities, including antioxidant, anti-inflammatory, antimicrobial, and anticancer effects. Despite these advantages, the clinical application of herbal drugs remains limited due to several inherent challenges.One of the major drawbacks associated with herbal formulations is the poor physicochemical and pharmacokinetic profile of many phytoconstituents. These compounds often exhibit low aqueous solubility, poor permeability across biological membranes, rapid metabolic degradation, and insufficient systemic bioavailability. Additionally, lack of target specificity and variability in composition further reduce their therapeutic effectiveness. As a result, higher doses are often required, which may lead to inconsistent outcomes and reduced patient compliance.To address these limitations, nanotechnology has emerged as a promising and innovative approach in drug delivery. Nanotechnology involves the design and application of materials at the nanoscale (typically 1–100 nm), where unique physicochemical properties such as increased surface area, enhanced reactivity, and improved interaction with biological systems can be achieved. These properties make nanocarriers highly suitable for delivering bioactive compounds with improved efficiency and precision.
In recent years significant progress has been made in the development of nano-based delivery systems specifically for herbal drugs. Various nanocarriers such as polymeric nanoparticles, solid lipid nanoparticles, liposomes, nanoemulsions, dendrimers, and phytosomes have been extensively investigated for their ability to enhance solubility, stability, and bioavailability of plant-derived compounds. Moreover, advancements in green nanotechnology have enabled the synthesis of nanoparticles using plant extracts, reducing the use of toxic chemicals and making the process more environmentally sustainable.Another notable advancement is the development of stimuli-responsive (smart) nanocarriers, which can release drugs in response to specific triggers such as pH, temperature, or enzymatic activity. These systems allow precise control over drug release and improve targeting efficiency, particularly in diseases like cancer. Additionally, the integration of artificial intelligence (AI) and computational modeling in nanocarrier design has accelerated the optimization of drug delivery systems by predicting drug–carrier interactions and improving formulation strategies.Furthermore, nano-herbal drug delivery systems take advantage of biological phenomena such as the enhanced permeability and retention (EPR) effect, which facilitates the accumulation of nanoparticles in diseased tissues, especially tumors. This targeted approach not only enhances therapeutic efficacy but also minimizes damage to healthy cells. Emerging delivery routes, including intranasal and transdermal nanoformulations, are also being explored for improved drug absorption and site-specific action.
The convergence of herbal medicine and nanotechnology has led to the development of a new field often referred to as nano-phytomedicine, which aims to combine the safety of natural products with the precision of modern drug delivery systems. This interdisciplinary approach holds immense potential in the management of chronic diseases such as cancer, diabetes, neurological disorders, and infections.
Despite these promising developments, several challenges remain, including concerns related to nanotoxicity, lack of standardized evaluation methods, regulatory hurdles, and scalability of production processes. Therefore, continued research and well-defined regulatory guidelines are essential for the successful translation of nano-herbal drug delivery systems from laboratory to clinical practice.
The therapeutic potential of herbal medicines is widely recognized; however, their successful clinical application is often restricted due to multiple physicochemical and biological limitations. Most phytoconstituents, including flavonoids, alkaloids, glycosides, and terpenoids, exhibit poor water solubility, limited permeability across biological membranes, and rapid degradation under physiological conditions. These drawbacks significantly reduce their bioavailability and therapeutic efficacy when administered through conventional dosage forms.
Another important concern is the first-pass metabolism in the liver, which leads to extensive degradation of many plant-derived compounds before they reach systemic circulation. Additionally, non-specific distribution of herbal drugs in the body may result in reduced concentration at the target site and possible off-target effects. Variability in plant composition and lack of uniform standardization further complicate their therapeutic use.
Nanotechnology-based drug delivery systems have been developed to address these challenges by modifying the pharmacokinetic and pharmacodynamic behavior of herbal drugs. The rationale behind using nanocarriers lies in their ability to improve the delivery, stability, and effectiveness of bioactive compounds at the molecular level.
Nano-sized carriers (typically ranging from 1 to 100 nm) possess unique properties such as high surface area-to-volume ratio, enhanced solubility, and improved interaction with biological membranes. These characteristics enable efficient encapsulation of phytoconstituents and facilitate their transport across physiological barriers.
One of the key advantages of nano-based systems is their ability to enhance solubility and dissolution rate of poorly water-soluble herbal compounds, thereby improving their absorption in the gastrointestinal tract. Furthermore, nanocarriers provide protection against chemical and enzymatic degradation, ensuring that the active constituents remain stable until they reach the target site.
Targeted drug delivery is another major rationale for the use of nanotechnology in herbal medicine. Surface modification of nanoparticles with ligands allows selective binding to specific cells or tissues, thereby increasing drug concentration at the desired site while minimizing systemic exposure. In addition, nano-herbal systems can exploit physiological phenomena such as the enhanced permeability and retention (EPR) effect, which promotes accumulation of nanoparticles in tumor tissues and inflamed areas.
Recent advancements have further strengthened the rationale for nano-based herbal drug delivery. The development of stimuli-responsive nanocarriers enables controlled drug release in response to environmental triggers such as pH, temperature, or enzymatic activity, improving therapeutic precision. Similarly, green synthesis approaches using plant extracts have gained attention for producing biocompatible and eco-friendly nanoparticles with reduced toxicity.
Moreover, the integration of artificial intelligence and machine learning in formulation design has allowed optimization of nanocarrier properties, prediction of drug–carrier interactions, and enhancement of formulation stability. These technological advancements contribute to the development of more efficient, safe, and personalized nano-herbal therapies.
In addition to improving therapeutic efficacy, nano-based systems also offer advantages such as reduced dosing frequency, improved patient compliance, and minimized adverse effects. Novel routes of administration, including transdermal, pulmonary, and intranasal delivery, are also being explored using nanotechnology to bypass traditional biological barriers and enhance drug delivery efficiency.
Overall, the rationale for employing nanotechnology in herbal drug delivery is based on its ability to overcome the inherent limitations of conventional herbal formulations and to provide a more effective, targeted, and patient-friendly therapeutic approach.
Nanocarriers play a crucial role in improving the delivery and therapeutic performance of herbal drugs. Based on their composition, structure, and functional properties, nanocarriers used in herbal drug delivery can be broadly classified into different categories. Each type offers specific advantages in terms of drug loading, stability, release behavior, and targeting efficiency.
Polymeric nanoparticles are solid colloidal systems composed of biodegradable polymers such as PLGA, chitosan, and alginate. Herbal bioactive compounds can be either encapsulated within the polymer matrix or adsorbed onto the surface.
These systems provide:
Recent advancements include the development of biodegradable and stimuli-responsive polymeric nanoparticles, which release drugs in response to environmental triggers like pH and temperature.
Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs)
Lipid-based nanocarriers are widely used for delivering lipophilic herbal compounds. Solid lipid nanoparticles are composed of solid lipids, whereas nanostructured lipid carriers contain a mixture of solid and liquid lipids.
Key advantages:
Recent research focuses on improving lipid composition and developing hybrid lipid nanocarriers for better encapsulation efficiency.
Liposomes
Liposomes are spherical vesicles consisting of phospholipid bilayers that can encapsulate both hydrophilic and lipophilic compounds.
They offer:
Modern developments include PEGylated liposomes and ligand-targeted liposomes, which improve circulation time and site-specific delivery.
Nanoemulsions
Nanoemulsions are fine oil-in-water or water-in-oil dispersions stabilized by surfactants, with droplet sizes in the nanometer range.
Benefits include:
Recent trends involve self-nanoemulsifying drug delivery systems (SNEDDS), which spontaneously form nanoemulsions in the gastrointestinal tract.
Phytosomes
Phytosomes are complexes formed by binding phytoconstituents with phospholipids, enhancing their ability to cross biological membranes.
Advantages:
Phytosomes are particularly useful for flavonoids and polyphenols, which otherwise show poor absorption.
Dendrimers
Dendrimers are highly branched, tree-like macromolecules with multiple functional groups on their surface, allowing efficient drug loading.
Features:
Recent research focuses on surface-modified dendrimers to reduce toxicity and improve biocompatibility.
Nanogels
Nanogels are cross-linked polymeric networks capable of holding large amounts of water while maintaining structural integrity.
They provide:
Nanogels are particularly promising for transdermal and localized delivery of herbal drugs.
Green-Synthesized (Plant-Based) Nanoparticles
A significant advancement in recent years is the development of nanoparticles using plant extracts as reducing and stabilizing agents.
Key features:
These nanoparticles combine the therapeutic effects of herbal compounds with nanotechnology, forming the basis of nano-phytomedicine.
Fig.1 classification of Nanocarries for herbal drug Delivery
Mechanism of Action of Nano-Based Herbal Drug Delivery Systems
Nano-based herbal drug delivery systems enhance therapeutic efficacy through a series of coordinated physicochemical and biological processes. These mechanisms ensure improved stability, targeted delivery, and controlled release of phytoconstituents, thereby overcoming the limitations of conventional herbal formulations.
Encapsulation of Phytoconstituents
The first step in nano-herbal drug delivery involves the incorporation of bioactive plant compounds into nanocarriers such as nanoparticles, liposomes, or nanoemulsions. The active constituents may be:
This encapsulation protects sensitive phytochemicals from environmental degradation (e.g., light, oxygen, pH, and enzymatic action), thereby preserving their therapeutic activity.
Protection from Degradation
Many herbal compounds are unstable in physiological conditions and undergo rapid degradation in the gastrointestinal tract or systemic circulation. Nanocarriers act as protective shields by:
This leads to increased availability of the active compound in its intact form.
Enhanced Absorption and Cellular Uptake
Due to their extremely small size (1–100 nm), nanocarriers can easily cross biological membranes. They improve drug absorption through:
This results in improved permeability and higher drug concentration in systemic circulation.
Targeted Drug Delivery
One of the most significant advantages of nano-based systems is their ability to deliver drugs specifically to diseased tissues.
Types of Targeting:
Passive targeting:
Utilizes the enhanced permeability and retention (EPR) effect, where nanoparticles accumulate in tumor or inflamed tissues due to leaky vasculature.
Active targeting:
Involves surface modification of nanocarriers with ligands (antibodies, peptides, etc.) that bind to specific receptors on target cells.
This targeted approach increases therapeutic efficiency and minimizes damage to healthy tissues.
Controlled and Sustained Drug Release
Nanocarriers are designed to release the drug in a controlled manner over a specific period. This helps in:
Recent Advances:
Stimuli-responsive systems
Drug release triggered by:
These “smart systems” provide precise control over when and where the drug is released.
Intracellular Delivery and Site-Specific Action
After reaching the target tissue, nanocarriers facilitate intracellular delivery of phytoconstituents by:
This ensures that the drug reaches its site of action at the cellular or molecular level.
Biodistribution and Reduced Toxicity
Nanocarriers alter the distribution pattern of drugs in the body:
This is particularly beneficial in diseases like cancer, where selective targeting is critical.
Role of Advanced Technologies
Recent developments have further refined the mechanism:
AI-assisted nanocarrier design: Optimizes size, charge, and drug release behavior
Surface engineering: Improves targeting efficiency
Hybrid nanocarriers: Combine multiple delivery mechanisms
Green-synthesized nanoparticles: Enhance biocompatibility and safety
These innovations significantly improve the precision and effectiveness of nano-herbal drug delivery systems.
Fig.2 Mechanism of action of nanobased herbal drug Delivery system
Recent Developments in Nano-Based Herbal Drug Delivery Systems
In recent years, nano-based herbal drug delivery has undergone rapid evolution due to advancements in material science, biotechnology, and computational tools. These developments have significantly improved the efficiency, safety, and applicability of herbal therapeutics. The integration of nanotechnology with phytomedicine has given rise to innovative systems collectively known as nano-phytomedicines, which demonstrate superior therapeutic performance compared to conventional formulations.
Green Synthesis of Nanoparticles (Eco-Friendly Approach)
One of the most important recent advancements is the development of plant-mediated (green) synthesis of nanoparticles. In this approach, plant extracts act as reducing and stabilizing agents, eliminating the need for toxic chemicals.
Key Advantages:
This method has gained attention for producing nanoparticles with improved therapeutic properties and minimal environmental impact.
Stimuli-Responsive (Smart) Nanocarriers
Modern nano-herbal systems are designed to respond to specific physiological conditions, leading to controlled and site-specific drug release.
Types of Stimuli:
These “smart nanocarriers” allow precise delivery of herbal drugs, especially in cancer and inflammatory diseases, improving treatment outcomes.
Artificial Intelligence (AI) in Nanocarrier Design
A major breakthrough is the integration of artificial intelligence and machine learning in drug delivery system design.
Applications:
AI significantly reduces trial-and-error experiments and accelerates the development of efficient nano-herbal formulations.
Targeted and Ligand-Functionalized Nanoparticles
Recent research focuses on active targeting strategies, where nanocarriers are modified with ligands such as antibodies, peptides, or receptors.
Benefits:
These systems are widely explored in cancer therapy and neurological disorders.
Advanced Nanocarrier Systems
New-generation nanocarriers have been developed with enhanced functionality:
? Hybrid Nanocarriers
Combination of polymeric + lipid systems for improved stability and drug loading
? Nanostructured Lipid Carriers (NLCs)
Improved version of solid lipid nanoparticles with higher encapsulation efficiency
? Dendrimers & Nanogels
Provide precise control over drug release and targeting
These systems improve pharmacokinetic properties and therapeutic outcomes of herbal drugs
Brain Targeting & Intranasal Delivery
Recent advancements include intranasal nanoformulations, which bypass the blood–brain barrier and deliver drugs directly to the brain.
Applications:
Nanocarriers improve delivery of herbal neuroprotective agents, enhancing therapeutic effectiveness.
Enhanced Bioavailability of Phytoconstituents
Nanoformulations have been shown to significantly improve the bioavailability of poorly soluble compounds such as:
Nanocarriers enhance solubility, stability, and absorption, leading to better therapeutic outcomes
Application in Chronic and Complex Diseases
Recent studies demonstrate the application of nano-herbal systems in:
Nanoformulations improve drug distribution, reduce toxicity, and enhance therapeutic efficiency.
Nanotechnology in Nutraceuticals and Functional Foods
An emerging area is the use of nano-herbal systems in food and nutrition:
Safety and Regulatory Advancements
Recent research also emphasizes:
Although nano-herbal systems show great promise, safety and large-scale production remain key challenges.
Therapeutic Applications of Nano-Based Herbal Drug Delivery Systems
Nano-based herbal drug delivery systems have opened new possibilities in the treatment of a wide range of diseases by enhancing the therapeutic efficiency, stability, and targeting of phytoconstituents. The integration of nanotechnology with herbal medicine has significantly improved clinical outcomes in both acute and chronic disorders. Recent research (2023–2025) highlights their expanding role across multiple therapeutic areas.
Cancer Therapy
Cancer treatment is one of the most extensively explored areas for nano-herbal drug delivery.
Key Contributions:
Targeted delivery of anticancer phytochemicals
Phytochemicals such as curcumin, resveratrol, and paclitaxel (plant-derived) show improved anticancer activity when delivered through nanocarriers. Advanced systems like ligand-functionalized nanoparticles allow selective targeting of cancer cells, minimizing damage to healthy tissues.
Antimicrobial and Antiviral Applications
Nano-herbal systems have demonstrated strong activity against resistant microorganisms.
Advantages:
Plant-derived nanoparticles, especially those synthesized through green methods, exhibit synergistic antimicrobial effects. These systems are being investigated for use against multidrug-resistant bacteria and emerging viral infections.
Cardiovascular Diseases
Herbal compounds with cardioprotective properties often suffer from poor bioavailability. Nanotechnology enhances their therapeutic impact.
Benefits:
Nanoformulations ensure sustained release and improved circulation time, leading to better management of cardiovascular conditions.
Diabetes Management
Nano-herbal drug delivery systems are increasingly used for the management of diabetes.
Mechanisms:
Improved bioavailability of antidiabetic phytoconstituents
Sustained release leading to stable blood glucose levels
Enhanced pancreatic protection and insulin sensitivity
These systems help in reducing dosing frequency and improving patient compliance.
Neurological Disorders (Brain Targeting)
One of the most promising recent developments is the use of nanocarriers for brain-targeted delivery.
Applications:
Nanoformulations, especially intranasal delivery systems, can bypass the blood–brain barrier and deliver herbal neuroprotective agents directly to the brain, enhancing therapeutic outcomes.
Anti-Inflammatory and Analgesic Applications
Many herbal drugs possess anti-inflammatory properties but suffer from poor delivery.
Advantages of Nanocarriers:
Nano-herbal formulations improve the management of chronic inflammatory conditions such as arthritis.
Dermatological Applications
Nano-herbal systems are widely used in topical and cosmetic formulations.
Applications:
Nanoemulsions and nanogels enhance the delivery of herbal compounds through the skin, increasing their effectiveness.
Antioxidant and Immunomodulatory Effects
Herbal compounds are rich in antioxidants but often show limited bioavailability.
Role of Nanotechnology:
Nano-herbal formulations are being explored for boosting immunity and preventing chronic diseases.
Application in Gastrointestinal Disorders
Nanocarriers improve the stability of herbal drugs in the gastrointestinal environment.
Benefits:
These systems are useful in treating ulcers, inflammatory bowel disease, and other GI disorders.
Nutraceutical and Preventive Healthcare Applications
A growing area of research is the use of nano-herbal systems in nutraceuticals and functional foods.
Applications:
This approach bridges the gap between nutrition and medicine.
Benefits of Nano-Herbal Drug Delivery Systems
Nano-herbal drug delivery systems offer significant advantages over conventional herbal formulations by improving the pharmacological performance of phytoconstituents. These benefits arise from the unique physicochemical properties of nanocarriers and their ability to interact efficiently with biological systems.
Enhanced Bioavailability
One of the primary advantages of nano-herbal systems is the improvement in bioavailability of poorly soluble phytoconstituents.
Increased surface area enhances dissolution rate
Improved permeability across biological membranes
Better absorption in the gastrointestinal tract
This leads to higher drug concentration in systemic circulation and improved therapeutic outcomes.
Targeted Drug Delivery
Nanocarriers can deliver herbal drugs specifically to diseased tissues.
Passive targeting via enhanced permeability and retention (EPR) effect
Active targeting through ligand modification
This selective delivery minimizes damage to healthy tissues and enhances treatment efficiency.
Controlled and Sustained Drug Release
Nano-based systems are designed to release drugs gradually over time.
Maintains consistent therapeutic levels
Reduces dosing frequency
Improves patient compliance
Recent advances include stimuli-responsive systems that release drugs in response to pH, temperature, or enzymes.
Protection of Phytoconstituents
Nanocarriers protect sensitive herbal compounds from degradation caused by:
This ensures stability and preservation of therapeutic activity.
Dose Reduction and Reduced Side Effects
Due to improved targeting and efficiency:
This is particularly beneficial in chronic disease management.
Improved Cellular Uptake
Nano-sized particles facilitate better penetration into cells through:
This leads to improved intracellular delivery of active compounds.
Versatility in Drug Delivery Routes
Nano-herbal systems can be administered through multiple routes:
Oral
Transdermal
Intranasal
Pulmonary
Recent developments highlight intranasal and transdermal nanoformulations for improved targeting and absorption.
Eco-Friendly and Biocompatible Systems
Green-synthesized nanoparticles using plant extracts offer:
This aligns with the growing demand for safer and eco-friendly therapeutics.
Challenges and Constraints
Despite the promising potential of nano-herbal drug delivery systems, several challenges must be addressed before their widespread clinical application.
Nanotoxicity and Safety Concerns
The small size and high reactivity of nanoparticles may lead to:
Long-term safety data is still limited, making toxicity evaluation essential.
Lack of Standardization
Herbal drugs inherently show variability due to:
This variability makes it difficult to standardize nano-herbal formulations.
Scale-Up and Manufacturing Challenges
Production of nano-herbal systems at an industrial scale faces difficulties:
Maintaining consistency during large-scale manufacturing is a major challenge.
Regulatory and Approval Issues
There is a lack of well-defined regulatory guidelines for nano-herbal products.
This creates barriers for commercialization.
High Cost of Development
Development of nano-based systems requires:
These factors increase the overall cost of formulation.
Stability Issues
Some nanocarriers may face stability problems such as:
Proper formulation strategies are needed to overcome these issues.
Limited Clinical Studies
Although many studies show promising results in laboratory conditions:
This slows down their acceptance in mainstream medicine.
Technological Limitations (Recent Concern)
While advanced technologies like AI are being used:
Fig.3 challenges and constraints
Future Perspectives of Nano-Based Herbal Drug Delivery Systems
The integration of nanotechnology with herbal medicine has opened promising avenues for the development of more effective and safer therapeutic systems. Despite significant progress, future research is essential to fully realize the clinical potential of nano-based herbal drug delivery systems. Emerging trends and technological advancements are expected to address existing limitations and expand their applications in modern medicine.
Development of Safer and Biocompatible Nanocarriers
Future research should focus on designing nanocarriers that are:
The use of natural polymers and plant-based materials is expected to reduce toxicity and improve safety profiles.
Advancement in Green Nanotechnology
Green synthesis of nanoparticles using plant extracts will play a major role in future developments.
This approach supports the concept of environmentally responsible nanomedicine.
Integration of Artificial Intelligence and Machine Learning
Artificial intelligence (AI) is expected to revolutionize nano-herbal drug delivery by:
AI-driven models will enable the design of more precise and efficient drug delivery systems.
Personalized and Precision Medicine
Future nano-herbal systems may be tailored according to individual patient needs.
This shift toward personalized medicine will enhance treatment efficacy.
Advanced Targeting Strategies
New targeting approaches are expected to improve specificity:
These strategies will be particularly useful in treating complex diseases such as cancer and neurological disorders.
Expansion of Smart (Stimuli-Responsive) Systems
The development of advanced smart nanocarriers will allow:
Future systems may respond to multiple stimuli simultaneously, enhancing precision.
Increased Clinical Research and Trials
To ensure clinical acceptance, future efforts must focus on:
This will help bridge the gap between laboratory research and clinical application.
Strengthening Regulatory Frameworks
Clear and well-defined regulatory guidelines are essential for commercialization.
Global regulatory harmonization will facilitate market approval and public acceptance.
Industrial Scale-Up and Commercialization
Future research should address manufacturing challenges by:
This will support large-scale production and widespread availability.
Expansion into New Therapeutic Areas
Nano-herbal drug delivery systems are expected to expand into:
This interdisciplinary growth will broaden their impact in healthcare.
CONCLUSION
Nanotechnology-based herbal drug delivery systems represent a significant advancement in the field of modern therapeutics by effectively bridging the gap between traditional medicine and contemporary pharmaceutical science. Herbal medicines, despite their extensive therapeutic potential and long history of use, often face critical challenges such as poor solubility, low bioavailability, instability, and lack of target specificity. The application of nanotechnology has provided innovative and efficient solutions to overcome these limitations.
Nanocarrier systems including polymeric nanoparticles, lipid-based carriers, liposomes, nanoemulsions, phytosomes, dendrimers, and nanogels have demonstrated remarkable ability to enhance the pharmacokinetic and pharmacodynamic properties of phytoconstituents. These systems improve drug solubility, protect bioactive compounds from degradation, and enable controlled as well as targeted delivery. As a result, they significantly increase therapeutic efficacy while minimizing adverse effects and reducing the required dosage.
Recent advancements (2023–2025) have further accelerated the development of nano-herbal drug delivery systems. Innovations such as green synthesis of nanoparticles, stimuli-responsive (smart) drug delivery systems, ligand-based targeting, and the integration of artificial intelligence in formulation design have improved precision, safety, and efficiency. Additionally, the exploration of novel administration routes, including intranasal and transdermal delivery, has expanded the applicability of these systems, particularly in complex conditions such as cancer, neurological disorders, and chronic diseases.
Despite these promising developments, several challenges remain, including concerns related to nanotoxicity, lack of standardized evaluation methods, regulatory uncertainties, high production costs, and difficulties in large-scale manufacturing. Furthermore, limited clinical data and insufficient long-term safety studies continue to hinder the widespread clinical adoption of nano-herbal formulations.
Looking ahead, the future of nano-herbal drug delivery systems lies in the development of safer, biodegradable, and more biocompatible nanocarriers, along with the implementation of robust regulatory frameworks and standardized quality control measures. The integration of emerging technologies such as artificial intelligence, machine learning, and personalized medicine is expected to further optimize drug delivery strategies and improve patient-specific treatment outcomes.
In conclusion, nano-based herbal drug delivery systems hold immense potential to revolutionize the pharmaceutical landscape by enhancing the effectiveness of natural therapeutics and providing innovative solutions for the management of various diseases. With continued research, technological advancements, and regulatory support, these systems are likely to play a crucial role in the future of global healthcare.
REFERENCES
Sakshi Mane, Pandurang Valekar, Akshay Thorat, Avinash Narale, Akshata Patil, Advancements in Nanotechnology-Driven Herbal Drug Delivery Systems: Current Progress, Limitations and Future Perspectives, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 4, 3449-3464, https://doi.org/10.5281/zenodo.19677483
10.5281/zenodo.19677483
